Combined-modality therapy for esophageal and gastroesophageal junction cancers

Medicine and Dentistry

• Malignant Neoplasm 100%
• Multimodality Cancer Therapy 100%
• Chemoradiotherapy 100%
• Gastroesophageal Junction 100%
• Disease 66%
• Preoperative Chemotherapy 66%
• Cisplatin 33%
• Esophageal Cancer 33%
• Fluorouracil 33%

Keyphrases

• Combined Modality Therapy 100%
• Gastroesophageal Junction Cancer 100%
• Surgery Alone 100%
• Concurrent Chemoradiotherapy 75%
• Preoperative Chemotherapy 50%
• 5-fluorouracil (5-FU) 25%
• Local Control 25%
• Cisplatin 25%
• Esophageal Cancer 25%
• Survival Benefit 25%
• Locoregional 25%
• Optimal Management 25%
• Distant Disease 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Chemoradiation Therapy 100%
• Disease 66%
• Chemotherapy 66%
• Fluorouracil 33%
• Cisplatin 33%
• Esophagus Cancer 33%